Literature DB >> 35298821

Computational Evolution Protocol for Peptide Design.

Rodrigo Ochoa1, Miguel A Soler2, Ivan Gladich3,4, Anna Battisti4, Nikola Minovski5,6, Alex Rodriguez7, Sara Fortuna2,5, Pilar Cossio1,8, Alessandro Laio7,4.   

Abstract

Computational peptide design is useful for therapeutics, diagnostics, and vaccine development. To select the most promising peptide candidates, the key is describing accurately the peptide-target interactions at the molecular level. We here review a computational peptide design protocol whose key feature is the use of all-atom explicit solvent molecular dynamics for describing the different peptide-target complexes explored during the optimization. We describe the milestones behind the development of this protocol, which is now implemented in an open-source code called PARCE. We provide a basic tutorial to run the code for an antibody fragment design example. Finally, we describe three additional applications of the method to design peptides for different targets, illustrating the broad scope of the proposed approach.
© 2022. The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Affinity optimization; Antibody design; Consensus scoring functions; Evolutionary algorithm; In silico antibody maturation; Molecular dynamics; Peptide design; Sensor technology

Mesh:

Substances:

Year:  2022        PMID: 35298821     DOI: 10.1007/978-1-0716-1855-4_16

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  40 in total

Review 1.  Nanomedicine.

Authors:  Betty Y S Kim; James T Rutka; Warren C W Chan
Journal:  N Engl J Med       Date:  2010-12-16       Impact factor: 91.245

Review 2.  Rational, computer-enabled peptide drug design: principles, methods, applications and future directions.

Authors:  David J Diller; Jon Swanson; Alexander S Bayden; Mark Jarosinski; Joseph Audie
Journal:  Future Med Chem       Date:  2015-10-29       Impact factor: 3.808

Review 3.  Targeting "Undruggable" Proteins: Design of Synthetic Cyclopeptides.

Authors:  Anna Russo; Carmela Aiello; Paolo Grieco; Daniela Marasco
Journal:  Curr Med Chem       Date:  2016       Impact factor: 4.530

Review 4.  Protein and peptide arrays: recent trends and new directions.

Authors:  Marina Cretich; Francesco Damin; Giovanna Pirri; Marcella Chiari
Journal:  Biomol Eng       Date:  2006-03-09

Review 5.  Synthetic therapeutic peptides: science and market.

Authors:  Patrick Vlieghe; Vincent Lisowski; Jean Martinez; Michel Khrestchatisky
Journal:  Drug Discov Today       Date:  2009-10-30       Impact factor: 7.851

Review 6.  Peptide therapeutics: current status and future directions.

Authors:  Keld Fosgerau; Torsten Hoffmann
Journal:  Drug Discov Today       Date:  2014-10-17       Impact factor: 7.851

7.  Phage Display to Detect and Identify Autoantibodies in Disease.

Authors:  Susan Deutscher
Journal:  N Engl J Med       Date:  2019-07-04       Impact factor: 91.245

Review 8.  The future of peptides in cancer treatment.

Authors:  Kaido Kurrikoff; David Aphkhazava; Ülo Langel
Journal:  Curr Opin Pharmacol       Date:  2019-03-08       Impact factor: 5.547

Review 9.  Protein-peptide docking: opportunities and challenges.

Authors:  Maciej Ciemny; Mateusz Kurcinski; Karol Kamel; Andrzej Kolinski; Nawsad Alam; Ora Schueler-Furman; Sebastian Kmiecik
Journal:  Drug Discov Today       Date:  2018-05-04       Impact factor: 7.851

10.  Quantification of Circulating Cancer Biomarkers via Sensitive Topographic Measurements on Single Binder Nanoarrays.

Authors:  Elena Ambrosetti; Pamela Paoletti; Alessandro Bosco; Pietro Parisse; Denis Scaini; Elda Tagliabue; Ario de Marco; Loredana Casalis
Journal:  ACS Omega       Date:  2017-06-13
View more
  1 in total

1.  In Silico Maturation of a Nanomolar Antibody against the Human CXCR2.

Authors:  Damiano Buratto; Yue Wan; Xiaojie Shi; Guang Yang; Francesco Zonta
Journal:  Biomolecules       Date:  2022-09-13
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.